8Indexed trials
mesh condition
Narcolepsy
Intelligence
Narcolepsy intelligence: 8 indexed trials, 3 recruiting studies, 7 sponsors across 12 countries.
3Recruiting
7Sponsors
12Countries
Leading sponsors
NLS Pharmaceutics20 recruiting
Jazz Pharmaceuticals10 recruiting
Johannes Gutenberg University Mainz11 recruiting
Eisai Inc.11 recruiting
Sanford Health11 recruiting
University Hospital, Montpellier10 recruiting
Vallon Pharmaceuticals, Inc.10 recruiting
Geographic activity
United States6trials
Germany2trials
Canada1trials
China1trials
France1trials
Australia1trials
Japan1trials
South Korea1trials
Spain1trials
Switzerland1trials
Italy1trials
Belgium1trials
Leading interventions
ADAIR 10 mg IR tablets1trials
ADX-N051trials
E20861trials
Implantation of vagus nerve stimulation according to clinical indication1trials
Mazindol1trials
PET-scan18F-AV-451trials
d-amphetamine sulfate1trials
mazindol extended release1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.